EUVIMEDEUVIMED entdecken
Open Access

Sarcomas With RAD51B Fusions Are Associated With a Heterogeneous Phenotype

Hsin-Yi Chang, Josephine Dermawan, Aarti Sharma, Brendan Dickson, Gulisa Turashvili, Dianne Torrence, Marisa Nucci, Sarah Chiang, Esther Oliva, Martina Kirchner, Albrecht Stenzinger, Gunhild Mechtersheimer und 1 weitere

Modern Pathology · 2024

DOI: 10.1016/j.modpat.2023.100402 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Pathology, 2024. Verfasst von Hsin-Yi Chang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Department of Pathology and Laboratory Medicine, M…. Hauptthemen laut MEDLINE: Sarcoma, Leiomyosarcoma, Perivascular Epithelioid Cell Neoplasms, Soft Tissue Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

RAD51B-rearranged sarcomas are rare neoplasms that exhibit a heterogeneous morphology. To date, 6 cases have been reported, all involving the uterus, including 4 perivascular epithelioid cell tumors (PEComas) and 2 leiomyosarcomas (LMS). In this study, we describe the morphologic, immunohistochemical, and molecular features of 8 additional sarcomas with RAD51B rearrangement, including the first extrauterine example. All patients were women with a median age of 57 years at presentation. Seven tumors originated in the uterus, and one in the lower extremity soft tissue, with a median tumor size of 12 cm. Histologically, 4 tumors showed predominantly spindle cell morphology with eosinophilic fibrillary cytoplasm, with or without nuclear pleomorphism, whereas 2 tumors exhibited pleomorphic epithelioid cells, featuring clear to eosinophilic, granular cytoplasm. Two neoplasms exhibited undifferentiated cytomorphology, including one with uniform small blue round cells. All tumors showed high-grade cytologic atypia and high mitotic activity (median: 30/10 high-power fields), whereas coagulative necrosis was noted in 6 cases and lymphovascular invasion in 2. By immunohistochemistry, 2 showed myoid and melanocytic markers in keeping with PEComa, whereas 4 cases were only positive for smooth muscle markers consistent with LMS (including 3 myxoid). The remaining 2 cases had a nonspecific immunoprofile. Five cases tested by targeted RNA sequencing (Archer FusionPlex, Illumina TruSight) showed different fusion partners (HMGA2, PDDC1, and CEP170). RAD51B rearrangements were identified by FISH in the remaining 3 cases. Targeted DNA sequencing in 2 cases was negative for TSC gene alterations. Clinical outcome, available in 5 patients (median follow-up, 19 months), revealed 3 local recurrences, 2 lung metastases, and 4 deaths due to disease. Our results expand the spectrum of sarcomas with RAD51B fusions, demonstrating variable clinical presentations, morphologic spectrum, and fusion partners. These tumors have a predilection for a uterine location, with either LMS, PEComa, or undifferentiated phenotypes, and are associated with an aggressive clinical course.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcomaLeiomyosarcomaPerivascular Epithelioid Cell NeoplasmsSoft Tissue NeoplasmsHumansFemaleMiddle AgedMaleBiomarkers, TumorPhenotypeDNA-Binding Proteins

Stichwörter der Autor:innen

PEComaRAD51Bfusionleiomyosarcomauterus

Substanzen

Biomarkers, TumorRAD51B protein, humanDNA-Binding Proteins

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio.
  • Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Department of Pathology & Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada.
  • Department of Pathology and Laboratory Medicine, Emory University Hospital, Atlanta, Georgia.
  • Department of Pathology, Northwell Health, New York, New York.

Förderung

  • NCI NIH HHS

Zitieren

APA

Chang, H. Y., Dermawan, J., Sharma, A., Dickson, B., Turashvili, G., Torrence, D., Nucci, M., Chiang, S., Oliva, E., Kirchner, M., Stenzinger, A., Mechtersheimer, G., & Antonescu, C. (2024). Sarcomas With RAD51B Fusions Are Associated With a Heterogeneous Phenotype. Modern Pathology. https://doi.org/10.1016/j.modpat.2023.100402

Vancouver

Chang HY, Dermawan J, Sharma A, Dickson B, Turashvili G, Torrence D, et al. Sarcomas With RAD51B Fusions Are Associated With a Heterogeneous Phenotype. Modern Pathology. 2024. doi:10.1016/j.modpat.2023.100402

BibTeX
@article{Chang2024,
  author = {Chang, Hsin-Yi and Dermawan, Josephine and Sharma, Aarti and Dickson, Brendan and Turashvili, Gulisa and Torrence, Dianne and Nucci, Marisa and Chiang, Sarah and Oliva, Esther and Kirchner, Martina and Stenzinger, Albrecht and Mechtersheimer, Gunhild and Antonescu, Cristina},
  title = {Sarcomas With RAD51B Fusions Are Associated With a Heterogeneous Phenotype},
  journal = {Modern Pathology},
  year = {2024},
  doi = {10.1016/j.modpat.2023.100402}
}
Kostenlos starten →